Thomas E. Daley
Oprichter bij Selva Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Thomas E. Daley
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 29 | |
Empire Biotechnologies, Inc.
 Empire Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Empire Biotechnologies, Inc. engages in the development of an orally delivered, therapeutic protein capable of significantly increasing the absorption of nutrients in the intestine. It focuses on treating malabsorption resulting from diseases and syndromes including short bowel syndrome, nectotizing enterocolotis, cystic fibrosis, wasting syndrome, and infant prematurity. The company was founded by Donald McCarthy and Piero Mendez and is headquartered in San Franciso, CA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Selva Therapeutics, Inc.
 Selva Therapeutics, Inc. BiotechnologyHealth Technology Selva Therapeutics, Inc. is a privately held biotechnology company that is dedicated to developing therapeutics for infectious diseases. The company is based in Del Mar, CA. The company's main focus is on rapidly developing SLV213 for COVID-19, which has the potential to fight multiple life-threatening infectious diseases. Selva Therapeutics was founded by Thomas E. Daley and Felix Wilhelm Frueh, and Thomas E. Daley has been the CEO since incorporation.
1
| Holding Company | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thomas E. Daley via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Director/Board Member | |
| PURE BIOSCIENCE, INC. | Chemicals: Major Diversified | Director of Finance/CFO | |
| NOVADEL PHARMA INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| XOMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer Founder Director of Finance/CFO Director/Board Member Director/Board Member | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Compliance Officer | |
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Director of Finance/CFO Comptroller/Controller/Auditor | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
O'Melveny & Myers LLP
 O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services O'Melveny & Myers LLP provides legal services. Its practice areas include labor and employment, litigation, tax, and transactions. The firm serves high-tech companies in the areas of legal advice related to software licensing, intellectual property, and venture capital investments. The company was founded by Henry William O'Melveny in 1885 and is headquartered in Los Angeles. CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Glyko, Inc.
 Glyko, Inc. Medical SpecialtiesHealth Technology Part of BioMarin Pharmaceutical, Inc., Glyko, Inc. discovers, develops, and commercializes carbohydrate enzyme therapeutics. The company is based in Novato, CA. Glyko was acquired by BioMarin Pharmaceutical, Inc. on October 08, 1998 for $14.50 million. | Medical Specialties | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member | |
Phairson Medical Ltd.
 Phairson Medical Ltd. Miscellaneous Commercial ServicesCommercial Services Phairson Medical Ltd. researches and develops novel biopharmaceutical products and devices. The private company is based in London, UK. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Brandeis University | College/University | Doctorate Degree | |
| University of Wisconsin | College/University | Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal Director of Finance/CFO Compliance Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
| THIOGENESIS THERAPEUTICS, CORP. | Financial Conglomerates | Director/Board Member Chairman Founder | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| The University of San Francisco School of Law | College/University | Graduate Degree | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Michigan-Dearborn | College/University | Undergraduate Degree | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member | |
| DMK PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| University of Kansas | College/University | Undergraduate Degree | |
| Boston University School of Medicine | College/University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Ierland | 2 |
| Zuid-Korea | 2 |
| Verenigd Koninkrijk | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Finance | 4 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 165 |
| Corporate Officer/Principal | 93 |
| Independent Dir/Board Member | 63 |
| Chairman | 44 |
| Chief Executive Officer | 42 |
Sterkste connecties
| Insiders | |
|---|---|
| Timothy Walbert | 40 |
| Georges Gemayel | 33 |
| Llew Keltner | 32 |
| Gregg Lapointe | 25 |
| Erich Sager | 21 |
| Kenneth Kelley | 19 |
| Georgia Erbez | 18 |
| Suzanne Bruhn | 18 |
| Craig Johnson | 17 |
| Rick Franklin | 17 |
| Krishna R. Polu | 16 |
| David Happel | 15 |
| Julie Smith | 15 |
| Vijay Samant | 15 |
| Raymond Anderson | 14 |
- Beurs
- Insiders
- Thomas E. Daley
- Bedrijfsconnecties
